Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically modified mouse that expresses human albumin

Genetically modified mouse that expresses human albumin

US Patent 11622547 · Granted Apr 11, 2023

Estimated economic value: $700,269,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or ag2025
Compositions and methods for treating sensorineural hearing loss using otoferlin2025
Models of tauopathy2025
Methods for producing antigen-binding proteins against foreign antigens2025
Immunoglobulin proteins that bind to NPR1 agonists2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025
Method of using a genetically modified mouse that expresses human albumin2025